We have recently received many enquiries from sisters preparing to come to Cambodia for IVF at DanRuo Hospital. Facing COVID-19 vaccination, everyone has more or less questions such as these:
Can I get vaccinated if I am preparing for IVF?
Can I get vaccinated if I am preparing for egg or sperm retrieval?
Can I get vaccinated if I am preparing for embryo transfer?
Can I get vaccinated after egg retrieval?
If I do get vaccinated, how long before I can have egg retrieval or transfer?
...
Based on the expert recommendations on COVID-19 vaccination for people planning pregnancy and those undergoing assisted-reproduction treatment, published in 2021 in the Chinese Journal of Reproductive Contraception, and the "Technical Guidelines for COVID-19 Vaccination (First Edition)" issued by the National Health Commission, we have organised the information everyone is concerned about, for your reference.
1. Recommendations of the Beijing Human Assisted-Reproduction Technology Quality Control and Improvement Center experts:
1. During the COVID-19 pandemic, women of reproductive age without relevant contraindications are advised to receive COVID-19 vaccination before pregnancy, especially those in high-exposure occupations and with various comorbidities, and women who would face potential pregnancy complications once pregnant.
2. For couples preparing to conceive naturally, there is no need to postpone pregnancy plans solely because of COVID-19 vaccination. If a COVID-19 vaccine was given while an existing pregnancy was unknown, termination of pregnancy is not recommended, but close follow-up observation is needed.
3. There is currently a lack of evidence on the long-term effects of COVID-19 vaccines on the reproductive system, gametes, embryos, and mother and child. For couples undergoing assisted-reproduction treatment, it is advised to start treatment one month after vaccination, once the immune response has stabilised. Couples of reproductive age who experience severe adverse reactions to vaccination should suspend starting treatment.
The above information is sourced from the expert recommendations on COVID-19 vaccination for people planning pregnancy and those undergoing assisted-reproduction treatment, in the Chinese Journal of Reproductive Contraception.
2. Types of COVID-19 vaccines currently available in China
1. Inactivated COVID-19 vaccine / conditionally approved for marketing
Principle: the virus is cultured and amplified using African green monkey kidney (Vero) cells, then inactivated with beta-propiolactone, retaining the antigen components to induce an immune response, with an aluminium hydroxide adjuvant added to enhance immunogenicity.
(1) Institute of Biological Products, Beijing, China National Biotec Group (Beijing Institute)
(2) Wuhan Institute of Biological Products Co., Ltd. (Wuhan Institute)
(3) Sinovac Research and Development Co., Ltd. (Sinovac)
2. Adenovirus-vector vaccine / conditionally approved for marketing
Principle: the gene for the SARS-CoV-2 spike glycoprotein (S protein) is recombined into a replication-deficient human adenovirus type 5; the recombinant adenovirus expresses the SARS-CoV-2 S-protein antigen in the body, inducing an immune response.
The recombinant COVID-19 vaccine (adenovirus type 5 vector) produced by CanSino Biologics Inc. (CanSino).
3. Recombinant subunit vaccine / approved for emergency use
Principle: the gene for the SARS-CoV-2 S-protein receptor-binding domain (RBD) is recombined into Chinese hamster ovary (CHO) cells, expressed in vitro to form RBD dimers, with an aluminium hydroxide adjuvant added to enhance immunogenicity.
Produced by Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (Zhifei Longcom).
The above information is sourced from the "Technical Guidelines for COVID-19 Vaccination (First Edition)" on the Healthy China public account of the National Health Commission.
3. Current doses and intervals for COVID-19 vaccination in China
1. Inactivated COVID-19 vaccine (Vero cells)
2 doses
The interval between the two doses is recommended to be at least 3 weeks
The second dose should be completed as early as possible within 8 weeks
2. Recombinant COVID-19 vaccine (adenovirus type 5 vector)
1 dose
3. Recombinant COVID-19 vaccine (CHO cells)
3 doses
The interval between adjacent doses is recommended to be at least 4 weeks
The second dose should be completed within 8 weeks after the first dose if possible
The third dose should be completed within 6 months after the first dose if possible
The above information is sourced from the "Technical Guidelines for COVID-19 Vaccination (First Edition)" on the Healthy China public account of the National Health Commission.
4. Who should not get a COVID-19 vaccine
How should the following groups get vaccinated? Please click the DXY (DingXiang Doctor) WeChat public-account article "Who should not get a COVID-19 vaccine? Read this and you'll know!" to view it.
Allergic diseases
Current fever
Acute illness
Chronic illness
Chronic diseases with impaired immune function
Special neurological diseases
Special circumstances in women
Before/after other vaccinations or medication
Other circumstances
5. Recent operations of the Cambodia DanRuo Hospital
Since the start of the global epidemic in early 2020, Cambodia DanRuo Hospital has operated normally throughout. While taking thorough epidemic precautions, whether clinical reproduction experts, embryologists, or front-desk and logistics nurses, everyone has remained at their posts, providing the expectant mothers who come to try to conceive during this special period with the same high-quality fertility-assistance care and thoughtful living services as ever.
There may be distance in the journey, but no limit to trust! Friends travel thousands of miles from China to Cambodia, and DanRuo Hospital, with everyone's support, has pressed forward against the current — this is the greatest recognition of DanRuo Hospital's technology, service and reputation.
The picture below shows the recent operating situation of DanRuo Hospital.










